Quality of Life and Satisfaction Level Following Thoracoscopic Sympathectomy: A 10 Year Follow-up
Presented During:
Monday, May 8, 2023: 3:27PM - 3:30PM
Los Angeles Convention Center
Posted Room Name:
Exhibit Hall
Abstract No:
P0144
Submission Type:
Abstract Submission
Authors:
Hussain AlShimali (1), Malak AlMojel (2), Abdullah AlElewah (2), Essa AlGhunaim (3), Adel Ayed (2), Diego Gonzalez Rivas (4), Derar Alshehab (2)
Institutions:
(1) N/A, N/A, (2) Chest diseases hospital, Kuwait, NA, (3) N/A, Kuwait, (4) shanghai Pulmonary hospital, Coruna, Galatia
Submitting Author:
Hussain Alshimali
-
Contact Me
N/A
N/A
Co-Author(s):
Malak AlMojel
-
Contact Me
Chest diseases hospital
Chest diseases hospital
Abdullah AlElewah
-
Contact Me
Chest diseases hospital
Chest diseases hospital
Essa AlGhunaim
-
Contact Me
N/A
N/A
Adel Ayed
-
Contact Me
Chest diseases hospital
Chest diseases hospital
*Diego Gonzalez Rivas
-
Contact Me
shanghai Pulmonary hospital
shanghai Pulmonary hospital
Derar Alshehab
-
Contact Me
Chest diseases hospital
Chest diseases hospital
Presenting Author:
Malak AlMojel
-
Contact Me
Chest diseases hospital
Chest diseases hospital
Abstract:
Objectives: Thoracoscopic (VATS) sympathectomy is considered one of the best treatment modalities for primary hyperhidrosis; however, this procedure is still surrounded by controversy with regards to its operative approaches, post-operative complications, and level of satisfaction in patients post-sympathectomy. The purpose of the study is to evaluate post-operative complications and level of satisfaction in 10-year follow-up, post VATS cauterizing sympathectomy.
Methods: this is a retrospective single institute review that enrolled patients undergoing single-staged cauterizing sympathectomy in a tertiary care center over the past 10 years. The rate of short-term, long-term complications was assessed by conducting a chart review. Level of patients' satisfaction was evaluated using quality of life questioner.
Results: total of 47 patients agreed to participate in our study, with males constituting 55.3% of the cohort. Majority of the study group 48.9% had a positive family history of hyperhidrosis in 1st degree relative, and 42.5% had failed a trial of Botox injection to maintain a long symptom-free period. Post-operatively, 31 patients had compensatory hyperhidrosis, mostly were in the back (61.7%) and stomach (48.9%), legs (31.8%); with median time to event of 32 days.
Thirty patients (63.8%) completed pre-operative and 10-year follow up post-operative personalized quality of life assessment, revealing significant improvement in the quality of life in all domains of questionnaire post-operatively (p-value <0.001), except wearing colored cloths.
Conclusion: VATS sympathectomy is a curative treatment in patients with primary hyperhidrosis with limited post-operative complications and significant upgrade in the quality of life post-operatively.
Methods: this is a retrospective single institute review that enrolled patients undergoing single-staged cauterizing sympathectomy in a tertiary care center over the past 10 years. The rate of short-term, long-term complications was assessed by conducting a chart review. Level of patients' satisfaction was evaluated using quality of life questioner.
Results: total of 47 patients agreed to participate in our study, with males constituting 55.3% of the cohort. Majority of the study group 48.9% had a positive family history of hyperhidrosis in 1st degree relative, and 42.5% had failed a trial of Botox injection to maintain a long symptom-free period. Post-operatively, 31 patients had compensatory hyperhidrosis, mostly were in the back (61.7%) and stomach (48.9%), legs (31.8%); with median time to event of 32 days.
Thirty patients (63.8%) completed pre-operative and 10-year follow up post-operative personalized quality of life assessment, revealing significant improvement in the quality of life in all domains of questionnaire post-operatively (p-value <0.001), except wearing colored cloths.
Conclusion: VATS sympathectomy is a curative treatment in patients with primary hyperhidrosis with limited post-operative complications and significant upgrade in the quality of life post-operatively.
THORACIC:
Chest Wall, Pleural and Mediastinal Disease
Image or Table
